Sonavex

Sonavex, Inc. is a Baltimore-based medical device company with a focus on "Empowered Patient Care". The firm, originally spun out of Johns Hopkins, has built a portfolio of innovative ultrasound solutions, which aim to empower patient care by delivering critical visual and quantitative data, thereby improving outcomes and reducing costs. One of Sonavex's key products, EchoMark, is a bioresorbable and highly echogenic (visible under ultrasound) implant used to mark at-risk blood vessels, enabling easy assessment for future complications. Additionally, EchoSure, another product by Sonavex, is a deep-learning enabled 3D automated ultrasound device designed to be used by healthcare providers without ultrasound training to evaluate blood flow and morphology of vessels marked by the implanted EchoMark device. The company, founded in 2013, operates in the Biotechnology and Health Care industries and is headquartered in the United States. Their latest investment round, a $1.70M grant, was secured on 25 May 2022 from the National Institutes of Health. For more information about Sonavex and their innovative medical solutions, visit their website at www.sonavex.com.